References
- Bouer A, Werther K, Catao-Dias JL, Nunes AL 1999. The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac. Fundam. Clin. Pharmacol. 13, 494–500.
- Calvo P, Vila-Jato JL, Alonso MJ 1997. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153, 41–50.
- Facklam MM, Burhenne J, Ding R, Fricker R, Mikus G, Zaman N T, Tam YK, Tawfik S, Wiltshire H 2004. Factors responsible for the variability of Saquinavir absorption: studies using an instrumented dog model. Pharm. Res. 21, 436–442.
- Frappier S, Breilh D, Diarte E, Ba B, Ducint, D, Pellegrin JL, Saux MC 1998. Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 714, 384–389.
- Gershanik T, Benzeno S, Benita S 1998. Interaction of a self emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm. Res. 15, 863–869.
- Illum L, Farraj NF, Davis SS 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11, 1186–1189.
- Jumaa M Muller BW, 1998a. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm. 163, 81–89.
- Jumaa M, Muller BW 1998b. The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant. Int. J. Pharm. 174, 29–37.
- Jumaa M, Muller BW, 1999. Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process. Int. J. Pharm. 183, 175–184.
- Kim RB, Fromm, MF, Wandel, C, Leake B, Wood, AJJ, Roden DM, Wilkinson GR 1998. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101, 289–294.
- Kotze AF, Lueβen HL, De BJ, Boer AG, Verhoef JC, Junginger, H 1998. Comparison of the effect of different chitosan salts and N-trimethylchitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Contr. Rel. 51:35–46.
- Kozte AF, Thanou MM, Lueßen HL, Boer AG, Verhoef JC, Junginger HE 1999. Effect of degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur. J. Pharm. Biopharm. 47, 269–274.
- Myers RA, Stella VJ 1992. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J. Pharm. 78, 217–220.
- Rubinstein A, Pathak YV, Kleinstein J, Reches A, Benita S 1991. In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsion. J. Pharm. Sci. 80, 643–647.
- Schipper NGM, Olsson S, Hoogstraate JA, Boer AG, Varum KM, Artursson P 1997. Chitosan as absorption enhancers for poorly absorbable drugs: mechanism of absorption enhancement. Pharm. Res. 14, 923–929.
- Thongborisute J, Takeuchi H, Yamamoto H,Kawashima Y 2006. Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J. Liposome Res. 16, 127–141.
- Uno T, Kazui T, Suzuki Y, Hashimoto H, Suzuki K, Muhammad, BA, 1999. Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route. Lipids 34, 249–254.
- Venkateswarlu V, Manjunath M, 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Contr. Rel. 95, 627–638.
- Yang SC, Benita S, 2000. Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev. Res. 50, 476–486.